Covance Not Cooling...
Health Care: Drugs
NuPathe Inc. (PATH: NASDAQ)
$3.20 0.05 | 1.59%
05/17/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 1.43M | 1.36M | 1.14M | -223,000 | -223,000 | 0 | 0 |
| Shares Bought | 1.43M | 1.36M | 1.36M | 0 | 0 | 0 | 0 |
| Shares Sold | 0 | 0 | 223,000 | 223,000 | 223,000 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 17.37M | 14.34M | 16.01M | 16.12M | 10.94M | 12.66M | 12.61M |
| Shares Bought | 7.11M | 4.44M | 4.44M | 5.13M | 2.60M | 5.05M | 5.00M |
| Shares Sold | 2.44M | 2.44M | 2.18M | 2.07M | 2.03M | 37,228 | 36,720 |
Portfolios with PATH
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorEarnings Short Squeeze Play...
- ContributorUnder-$10 Setting Up To Tra...
- UserSMITTY
- ContributorHot Biotech Trades for Seco...
- Contributor9 Health Care Stocks With 1...
Latest PATH Headlines from TheStreet
- 4 Health Care Stocks Under $10 to Watch 04.16.13 | 03:04 pm
- 5 Under-$10 Stocks Primed to Trade Higher 12.20.12 | 12:12 pm
- 2013 FDA Drug Approval Decision Calendar 12.19.12 | 09:12 am
- First 90 Days of 2013 Are Live or Die For These Biotech Stocks 11.19.12 | 09:11 am
- 5 Biotech Stocks Under $5 Blasting Off 08.16.12 | 03:08 pm
- NuPathe Management Discusses Q2 2012 Results - Earnings Call Transcript 08.14.12 | 02:08 pm
- 4 Stocks Under $5 Making Big Moves 07.17.12 | 12:07 pm
- 8 Stocks Under $10 Moving Higher 02.08.12 | 02:02 pm
- 11 Stocks to Watch: NuPathe, Universal Display 08.30.11 | 08:08 am
- FDA Rejects NuPathe Migraine Patch 08.30.11 | 06:08 am
Press Releases for PATH
- Safeguard Scientifics Announces Second Quarter 2011 Financial Results - Business Wire 07.27.11 | 06:07 am
Partner Headlines for PATH
- Pre-Market Earnings Report for March 26, 2013 : NEOG, PLCE, PATH - NASDAQ 03.25.13 | 08:03 pm
- Morning Market Losers - Benzinga 09.26.12 | 09:09 am
- 7 Biotech Stocks Being Snapped Up By Insiders - Seeking Alpha 03.16.12 | 05:03 pm
- Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha 03.16.12 | 08:03 am
- NuPathe Announces Allowance of U.S. Patent Application for NP202 - Benzinga 02.29.12 | 04:02 pm
- Nupathe's Zelrix Going Down A Path With Multiple Headwinds - Seeking Alpha 12.09.11 | 09:12 am
- 5 Healthcare Stocks To Consider - Seeking Alpha 09.01.11 | 08:09 am
- Mid-Day Update: US Indexes Recover from Red; Consumer Confidence Data Still Weighs - NASDAQ 08.30.11 | 04:08 pm
- Stocks Recover from Consumer Confidence Data-Induced Slump; Commodities Trending Higher - NASDAQ 08.30.11 | 04:08 pm
- Morning Market Losers - Benzinga 08.30.11 | 09:08 am
